Abstract
Summary
According to this study, the global Nucleic Acid-based Drugs market size will reach US$ million by 2029.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid-based Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
ASO
mRNA
siRNA
miRNA
saRNA
Aptamer
Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
BioNTech
Moderna Therapeutics
CureVac
Alnylam Pharmaceuticals
Regulus Therapeutics
Miragen Therapeutics
Mina Therapeutics
NeXstar Pharmaceuticals
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid-based Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
ASO
mRNA
siRNA
miRNA
saRNA
Aptamer
Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
BioNTech
Moderna Therapeutics
CureVac
Alnylam Pharmaceuticals
Regulus Therapeutics
Miragen Therapeutics
Mina Therapeutics
NeXstar Pharmaceuticals
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid-based Drugs Market Size 2024-2029
2.1.2 Nucleic Acid-based Drugs Market Size CAGR by Region
2.2 Nucleic Acid-based Drugs Segment by Type
2.2.1 ASO
2.2.2 mRNA
2.2.3 siRNA
2.2.4 miRNA
2.2.5 saRNA
2.2.6 Aptamer
2.3 Nucleic Acid-based Drugs Market Size by Type
2.3.1 Global Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029)
2.3.2 Global Nucleic Acid-based Drugs Market Size Growth Rate by Type (2024-2029)
2.4 Nucleic Acid-based Drugs Segment by Application
2.4.1 Genetic Disease
2.4.2 Cancer
2.4.3 Cardiovascular Diseases
2.4.4 Other
2.5 Nucleic Acid-based Drugs Market Size by Application
2.5.1 Global Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029)
2.5.2 Global Nucleic Acid-based Drugs Market Size Growth Rate by Application (2024-2029)
3 Nucleic Acid-based Drugs Key Players
3.1 Date of Key Players Enter into Nucleic Acid-based Drugs
3.2 Key Players Nucleic Acid-based Drugs Product Offered
3.3 Key Players Nucleic Acid-based Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Nucleic Acid-based Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Nucleic Acid-based Drugs by Regions
4.1 Nucleic Acid-based Drugs Market Size by Regions (2024-2029)
4.2 United States Nucleic Acid-based Drugs Market Size Growth (2024-2029)
4.3 China Nucleic Acid-based Drugs Market Size Growth (2024-2029)
4.4 Europe Nucleic Acid-based Drugs Market Size Growth (2024-2029)
4.5 Rest of World Nucleic Acid-based Drugs Market Size Growth (2024-2029)
5 United States
5.1 United States Nucleic Acid-based Drugs Market Size by Type (2024-2029)
5.2 United States Nucleic Acid-based Drugs Market Size by Application (2024-2029)
6 Europe
6.1 Europe Nucleic Acid-based Drugs Market Size by Type (2024-2029)
6.2 Europe Nucleic Acid-based Drugs Market Size by Application (2024-2029)
7 China
7.1 China Nucleic Acid-based Drugs Market Size by Type (2024-2029)
7.2 China Nucleic Acid-based Drugs Market Size by Application (2024-2029)
8 Rest of World
8.1 Rest of World Nucleic Acid-based Drugs Market Size by Type (2024-2029)
8.2 Rest of World Nucleic Acid-based Drugs Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Nucleic Acid-based Drugs
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Details
11.1.2 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Offered
11.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.1.4 Ionis Pharmaceuticals Main Business Overview
11.1.5 Ionis Pharmaceuticals News
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Nucleic Acid-based Drugs Product Offered
11.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.2.4 Sarepta Therapeutics Main Business Overview
11.2.5 Sarepta Therapeutics News
11.3 Nippon Shinyaku
11.3.1 Nippon Shinyaku Company Details
11.3.2 Nippon Shinyaku Nucleic Acid-based Drugs Product Offered
11.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.3.4 Nippon Shinyaku Main Business Overview
11.3.5 Nippon Shinyaku News
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Nucleic Acid-based Drugs Product Offered
11.4.3 BioNTech Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech News
11.5 Moderna Therapeutics
11.5.1 Moderna Therapeutics Company Details
11.5.2 Moderna Therapeutics Nucleic Acid-based Drugs Product Offered
11.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.5.4 Moderna Therapeutics Main Business Overview
11.5.5 Moderna Therapeutics News
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Nucleic Acid-based Drugs Product Offered
11.6.3 CureVac Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac News
11.7 Alnylam Pharmaceuticals
11.7.1 Alnylam Pharmaceuticals Company Details
11.7.2 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product Offered
11.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.7.4 Alnylam Pharmaceuticals Main Business Overview
11.7.5 Alnylam Pharmaceuticals News
11.8 Regulus Therapeutics
11.8.1 Regulus Therapeutics Company Details
11.8.2 Regulus Therapeutics Nucleic Acid-based Drugs Product Offered
11.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.8.4 Regulus Therapeutics Main Business Overview
11.8.5 Regulus Therapeutics News
11.9 Miragen Therapeutics
11.9.1 Miragen Therapeutics Company Details
11.9.2 Miragen Therapeutics Nucleic Acid-based Drugs Product Offered
11.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.9.4 Miragen Therapeutics Main Business Overview
11.9.5 Miragen Therapeutics News
11.10 Mina Therapeutics
11.10.1 Mina Therapeutics Company Details
11.10.2 Mina Therapeutics Nucleic Acid-based Drugs Product Offered
11.10.3 Mina Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.10.4 Mina Therapeutics Main Business Overview
11.10.5 Mina Therapeutics News
11.11 NeXstar Pharmaceuticals
12 Research Findings and Conclusion